HRAS and neoplasm: The tumor cell AR score, CHRA levels, apoptosis levels, or ERG score were not associated with outcome, and did not differ between patients with different metastasis subtypes (MetA-C), except for CHRA that was significantly lower in MetC compared to MetB patients (Supplement Fig. 1).